Success Metrics

Clinical Success Rate
76.2%

Based on 115 completed trials

Completion Rate
76%(115/151)
Active Trials
22(10%)
Results Posted
72%(83 trials)
Terminated
36(17%)

Phase Distribution

Ph early_phase_1
2
1%
Ph not_applicable
34
16%
Ph phase_2
46
21%
Ph phase_3
45
21%
Ph phase_4
57
27%
Ph phase_1
19
9%

Phase Distribution

21

Early Stage

46

Mid Stage

102

Late Stage

Phase Distribution203 total trials
Early Phase 1First-in-human
2(1.0%)
Phase 1Safety & dosage
19(9.4%)
Phase 2Efficacy & side effects
46(22.7%)
Phase 3Large-scale testing
45(22.2%)
Phase 4Post-market surveillance
57(28.1%)
N/ANon-phased studies
34(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.8%

115 of 158 finished

Non-Completion Rate

27.2%

43 ended early

Currently Active

22

trials recruiting

Total Trials

215

all time

Status Distribution
Active(28)
Completed(115)
Terminated(43)
Other(29)

Detailed Status

Completed115
Terminated36
unknown28
Recruiting18
Withdrawn7
Not yet recruiting6

Development Timeline

Analytics

Development Status

Total Trials
215
Active
22
Success Rate
76.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.0%)
Phase 119 (9.4%)
Phase 246 (22.7%)
Phase 345 (22.2%)
Phase 457 (28.1%)
N/A34 (16.7%)

Trials by Status

terminated3617%
active_not_recruiting42%
not_yet_recruiting63%
completed11553%
unknown2813%
recruiting188%
suspended10%
withdrawn73%

Recent Activity

Clinical Trials (215)

Showing 20 of 215 trialsScroll for more
NCT03765567Phase 4

Placement of Antibiotic Powder in Wounds During the Emergency Room

Recruiting
NCT05539729Phase 1

Vancomycin Study in Multiple Sclerosis (MS)

Recruiting
NCT06426836Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Recruiting
NCT03723551Phase 2

Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus

Terminated
NCT02667418Phase 4

Optimal Treatment for Recurrent Clostridium Difficile

Terminated
NCT06439953Not Applicable

Irrisept Solution for Instrumented Spine Surgery

Recruiting
NCT04017468Phase 2

Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion

Completed
NCT06582264Phase 1

A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

Completed
NCT04729322Phase 2

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Active Not Recruiting
NCT07282782Phase 4

Vancomycin in TKAs

Recruiting
NCT05137119Phase 4

Staphylococcus Aureus Network Adaptive Platform Trial

Recruiting
NCT07490054Phase 1

Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure

Recruiting
NCT03710122Phase 2

Vancomycin for Primary Sclerosing Cholangitis

Terminated
NCT02216227Not Applicable

Checklist to Prevent MRSA Surgical Site Infections

Completed
NCT06567808Phase 4

Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial

Not Yet Recruiting
NCT04872400Phase 4

Acute Application of Antibiotic Powder in Open Fracture Wounds

Completed
NCT07435051Phase 3

Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis

Not Yet Recruiting
NCT06954129Phase 4

A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients

Recruiting
NCT04793152Not Applicable

Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC

Recruiting
NCT04666948Phase 4

Precision Dosing of Vancomycin in Critically Ill Children

Completed

Drug Details

Intervention Type
DRUG
Total Trials
215